Identification and analysis of dominant negative mutants of RAIDD and PIDD

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1804, Issue 7, 2010, Pages 1557-1563

  Jang, Tae Ho ^a   Bae, Ju Young ^a   Park, Ok Kyoung ^a   Kim, Ji Hoe ^a   Cho, Kyung Hyun ^a   Jeon, Ju Hong ^b   Park, Hyun Ho ^a  

^a Yeungnam University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Apoptosis; Apoptosome; Caspase 2; DISC; Dominant negative mutant; Inflammation; PIDD PIDDosome; RAIDD

Indexed keywords

CELL PROTEIN; CRADD PROTEIN; ENZYME ACTIVATOR; PROTEIN PIDD; PROTEIN PIDDOSOME; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME SYNTHESIS; MUTANT; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY;

AMINO ACID SEQUENCE; APOPTOSIS; CARRIER PROTEINS; CASPASES; CRADD SIGNALING ADAPTOR PROTEIN; CYSTEINE PROTEASES; ENZYME ACTIVATION; GENES, DOMINANT; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTAGENS; POINT MUTATION; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION;

EID: 77952319102     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2010.04.006     Document Type: Article

References (41)

1. Kerr J.F., Wyllie A.H., and Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26 (1972) 239-257
2. Wyllie A.H., Kerr J.F., and Currie A.R. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68 (1980) 251-306
3. Rathmell J.C., and Thompson C.B. The central effectors of cell death in the immune system. Annu. Rev. Immunol. 17 (1999) 781-828
4. Park H.H., Lo Y.C., Lin S.C., Wang L., Yang J.K., and Wu H. The death domain superfamily in intracellular signaling of apoptosis and inflammation. Annu. Rev. Immunol. 25 (2007) 561-586
5. Nickoloff B.J., Qin J.Z., Chaturvedi V., Bacon P., Panella J., and Denning M.F. Life and death signaling pathways contributing to skin cancer. J. Investig. Dermatol. Symp. Proc. 7 (2002) 27-35
6. Rudin C.M., and Thompson C.B. Apoptosis and disease: regulation and clinical relevance of programmed cell death. Annu. Rev. Med. 48 (1997) 267-281
7. Talapatra S., and Thompson C.B. Growth factor signaling in cell survival: implications for cancer treatment. J. Pharmacol. Exp. Ther. 298 (2001) 873-878
8. Thompson T.C., and Yang G. Regulation of apoptosis in prostatic disease. Prostate Suppl. 9 (2000) 25-28
9. Denault J.B., and Salvesen G.S. Caspases: keys in the ignition of cell death. Chem. Rev. 102 (2002) 4489-4500
10. Salvesen G.S. Caspases and apoptosis. Essays Biochem. 38 (2002) 9-19
11. Salvesen G.S., and Riedl S.J. Caspase mechanisms. Adv. Exp. Med. Biol. 615 (2008) 13-23
12. Stennicke H.R., and Salvesen G.S. Caspases - controlling intracellular signals by protease zymogen activation. Biochim. Biophys. Acta 1477 (2000) 299-306
13. Boatright K.M., and Salvesen G.S. Mechanisms of caspase activation. Curr. Opin. Cell Biol. 15 (2003) 725-731
14. Denault J.B., and Salvesen G.S. Apoptotic caspase activation and activity. Meth. Mol. Biol. 414 (2008) 191-220
15. Stennicke H.R., and Salvesen G.S. Catalytic properties of the caspases. Cell Death Differ. 6 (1999) 1054-1059
16. Wajant H. The Fas signaling pathway: more than a paradigm. Science 296 (2002) 1635-1636
17. Wajant H. Death receptors. Essays Biochem. 39 (2003) 53-71
18. Zou H., Henzel W.J., Liu X., Lutschg A., and Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90 (1997) 405-413
19. Zou H., Li Y., Liu X., and Wang X. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274 (1999) 11549-11556
20. Martinon F., Mayor A., and Tschopp J. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27 (2009) 229-265
21. Martinon F., and Tschopp J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117 (2004) 561-574
22. Martinon F., Burns K., and Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 10 (2002) 417-426
23. Jang T.H., and Park H.H. Purification, crystallization and preliminary X-ray crystallographic studies of RAIDD Death-Domain (DD). Int. J. Mol. Sci. 10 (2009) 2501-2509
24. Park H.H., and Wu H. Crystal structure of RAIDD death domain implicates potential mechanism of PIDDosome assembly. J. Mol. Biol. 357 (2006) 358-364
25. Park H.H., and Wu H. Crystallization and preliminary X-ray crystallographic studies of the oligomeric death-domain complex between PIDD and RAIDD. Acta Crystallogr. Sect. F. Struct. Biol. Cryst. Commun. 63 (2007) 229-232
26. Tinel A., and Tschopp J. The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 304 (2004) 843-846
27. Lin Y., Ma W., and Benchimol S. Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis. Nat. Genet. 26 (2000) 122-127
28. Telliez J.B., Bean K.M., and Lin L.L. LRDD, a novel leucine rich repeat and death domain containing protein. Biochim. Biophys. Acta 1478 (2000) 280-288
29. Hsu H., Huang J., Shu H.B., Baichwal V., and Goeddel D.V. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4 (1996) 387-396
30. Duan H., and Dixit V.M. RAIDD is a new 'death' adaptor molecule. Nature 385 (1997) 86-89
31. Kelliher M.A., Grimm S., Ishida Y., Kuo F., Stanger B.Z., and Leder P. The death-domain kinase RIP mediates the TNF-induced NF-kB signal. Immunity 8 (1998) 297-303
32. Janssens S., Tinel A., Lippens S., and Tschopp J. PIDD mediates NF-kappaB activation in response to DNA damage. Cell 123 (2005) 1079-1092
33. Zhivotovsky B., and Orrenius S. Caspase-2 function in response to DNA damage. Biochem. Biophys. Res. Commun. 331 (2005) 859-867
34. Lassus P., Opitz-Araya X., and Lazebnik Y. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 297 (2002) 1352-1354
35. Wang L., Miura M., Bergeron L., Zhu H., and Yuan J. Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 78 (1994) 739-750
36. Reed J.C., Doctor K.S., and Godzik A. The domains of apoptosis: a genomics perspective. Sci. STKE (2004) re9 2004
37. Park H.H., Logette E., Raunser S., Cuenin S., Walz T., Tschopp J., and Wu H. Death domain assembly mechanism revealed by crystal structure of the oligomeric PIDDosome core complex. Cell 128 (2007) 533-546
38. Wu Z.H., Mabb A., and Miyamoto S. PIDD: a switch hitter. Cell 123 (2005) 980-982
39. Gudkov A.V., and Komarova E.A. The role of p53 in determining sensitivity to radiotherapy. Nat. Rev. Cancer. 3 (2003) 117-129
40. Gudkov A.V., and Komarova E.A. Prospective therapeutic applications of p53 inhibitors. Biochem. Biophys. Res. Commun. 331 (2005) 726-736
41. Komarov P.G., Komarova E.A., Kondratov R.V., Christov-Tselkov K., Coon J.S., Chernov M.V., and Gudkov A.V. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285 (1999) 1733-1737